Morgan Stanley analyst Thibault Boutherin upgraded Bayer (BAYRY) to Overweight from Equal Weight with a price target of EUR 40, up from EUR 29. The firm views the company as a “tactical valuation play” into 2026 due to its positive litigation developments and improving fundamentals.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY: